未登录 THE COST OF ACTIVE SURVEILLANCE IN MUSCLE-INVASIVE BLADDER CANCER FOR CLINICAL COMPLETE RESPONSE TO NEOADJUVANT SYSTEMIC THERAPY 肌层浸润性膀胱癌中，新辅助全身治疗达到临床完全缓解时主动监测的成本 Ranti, Daniel; Seo, Gabrielle; Wei, Nancy; Laplaca, Caroline Caroline; Pingle, Srinath Reddi; Joffe, Benjamin I.; Ghanta, Siddharth; Wooster, Margaux; Runcie, Karie; Wei, Alexander; Stein, Mark; Decastro, Guarionex J.; Anderson, Christopher; Mckiernan, James M.; Lenis, Andrew T. 分享 收藏
TREATMENT PATTERNS AND SURVIVAL IN VETERANS WITH HORMONE-SENSITIVE METASTATIC PROSTATE CANCER IMAGED WITH PSMA PET/CT 激素敏感性转移性前列腺癌患者经PSMA PET/CT影像的诊疗模式与生存情况 Allen, Harris; Wynveen, Molly; Escoto, Kathleen; Ghanta, Siddharth; Mundi, Prabhjot; Lin, Xiaojin; Stein, Mark N.; Sheth, Niki; Fojo, Antonio; Schoen, Martin W.; Faiena, Izak 分享 收藏
分享 收藏
分享 收藏
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma Wirth, Lena Vanessa; Hugaboom, Miya B.; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueiri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David F.; Plimack, Elizabeth R.; Sosman, Jeffrey; Haas, Naomi; Hurwitz, Michael E.; Hammers, Hans; Stein, Mark; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine J.; Braun, David 分享 收藏
CD163+Tumor-Associated macrophages and clinical outcomes to First-Line nivolumab therapy in patients with metastatic clear cel renal cell carcinoma: insights from the HCRN GU16-260 trial CD163+肿瘤相关巨噬细胞与转移性透明细胞肾细胞癌患者接受一线纳武利尤单抗治疗的临床结局：来自HCRN GU16-260试验的见解 Simsek, Berkay; Paul, Morgan A.; Xie, Wanling; El Ahmar, Nourhan; Matar, Sayed; Laimon, Yasmin Nabil; RobertiDe Oliveira, Gabriel; Mohanna, Razan; Delcea, Andrew; Choueri, Toni; Braun, David; Sun, Maxine; Haas, Naomi B.; Hammers, Hans J.; Bilen, Mehmet; Stein, Mark N.; Sosman, Jeffrey A.; Freeman, Gordon J.; Wu, Catherine; Mcdermott, David; Atkins, Michael B.; Signoretti, Sabina 分享 收藏
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma 三级淋巴结构的存在和耗竭性组织驻留T细胞决定了肾细胞癌对PD-1阻断的临床反应 Wirth, Lena; Hugaboom, Miya; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David; Plimack, Elizabeth; Sosman, Jeffrey A.; Haas, Naomi B.; Hurwitz, Michael; Hammers, Hans J.; Stein, Mark N.; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine; Braun, David 分享 收藏
分享 收藏
分享 收藏
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active Surveillance 肌层浸润性膀胱癌患者新辅助治疗后达到临床完全缓解后的管理：主动监测的证据与考量 Joffe, Benjamin I.; Christin, John R.; Coz, Clementine Le; Pingle, Srinath-Reddi; Wei, Alexander Z.; Runcie, Karie D.; Stein, Mark N.; Decastro, Guarionex Joel; Anderson, Christopher B.; Mckiernan, James M.; Lenis, Andrew T. 分享 收藏
分享 收藏
Tertiary Lymphoid Structures Predict Response to First-Line Nivolumab Therapy in Advanced Renal Cell Carcinoma: Findings from the HCRN GU16-260 Clinical Trial 三级淋巴结构预测晚期肾细胞癌一线Nivolumab治疗的反应: HCRN GU16-260临床试验的结果 El Ahmar, Nourhan; Simsek, Berkay; Jegede, Opeyemi; Matar, Sayed; Savla, Varunika; Laimon, Yasmin; Mohanna, Razan; De Oliveira, Gabriel Roberti; Sheshdeh, Aseman Baghari; Delcea, Andrew; Paul, Morgan; Choueiri, Toni; Xie, Wanling; Freeman, Gordon; Braun, David; Haas, Naomi Balzer; Hammers, Hans; Bilen, Mehmet; Stein, Mark; Sosman, Jeffrey; Wu, Catherine; Mcdermott, David; Atkins, Michael; Signoretti, Sabina 分享 收藏
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial 靶向PSCA的BPX-601 CAR T细胞通过雷米杜西布药理学激活在转移性胰腺癌和前列腺癌中的应用：一项1期剂量递增试验 Stein, Mark N.; Teply, Benjamin A.; Gergis, Usama S.; Guiterrez, Martin E.; Subudhi, Sumit K.; Jacquemont, Celine F.; Senesac, Joseph H.; Bayle, J. Henri; Scripture, Charity D.; Chatwal, Monica S.; Bilen, Mehmet A.; Stadler, Walter M.; Becerra, Carlos R. 分享 收藏
A phase II trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder 一项关于卡巴他赛、吉西他滨和顺铂（CGC）膀胱内灌注治疗非肌层浸润性卡介苗难治性膀胱尿路上皮癌的II期临床试验 DeCastro, G. J.; Stein, M.; Abate-Shen, C.; Miles, C.; Gray, J.; Joffe, B.; Anderson, C.; Lenis, A.; McKiernan, J. M. M. 分享 收藏
A phase I, first-in-human, open-label, multicenter, trial-in-progress of the safety, tolerability, and preliminary efficacy of JNJ-87189401 (PSMA-CD28 bispecific antibody) combined with JNJ-78278343 (KLK2-CD3 bispecific antibody) for advanced prostate cancer 一项关于JNJ-87189401（PSMA-CD28双特异性抗体）联合JNJ-78278343（KLK2-CD3双特异性抗体）治疗晚期前列腺癌的安全性、耐受性及初步疗效的I期、首次人体试验、开放标签、多中心、进行中的临床试验。 Stein, M. N.; Graham, L. S.; Baldini, C.; Vinceneux, A.; Kessler, E.; Runcie, K.; Wei, A. Z.; Papadopoulos, K. P.; Bernard-Tessier, A.; Laurent, M.; Jaiprasart, P.; Thaper, D.; Shen, F.; Cartee, L.; Attiyeh, E.; Villalobos, V. M.; Rasco, D. 分享 收藏
Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial Lara, Primo N., Jr.; Tangen, Catherine; Heath, Elisabeth I.; Gulati, Shuchi; Stein, Mark N.; Meng, Maxwell; Alva, Ajjai Shivaram; Pal, Sumanta K.; Puzanov, Igor; Clark, Joseph I.; Choueiri, Toni K.; Agarwal, Neeraj; Uzzo, Robert; Haas, Naomi B.; Synold, Timothy W.; Plets, Melissa; Vaishampayan, Ulka N.; Shuch, Brian M.; Lerner, Seth; Thompson, Ian M., Jr.; Ryan, Christopher W. 分享 收藏
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A) nivolumab和savage nivolumab/ipilimumab治疗晚期透明细胞肾细胞癌的II期研究的无治疗生存结果 (HCRN GU16-260-Cohort A) Atkins, Michael B.; Jegede, Opeyemi A.; Haas, Naomi B.; Mcdermott, David F.; Bilen, Mehmet A.; Stein, Mark; Sosman, Jeffrey; Alter, Robert; Plimack, Elizabeth R.; Ornstein, Moshe C.; Hurwitz, Michael; Peace, David J.; Einstein, David; Catalano, Paul J.; Hammers, Hans; Regan, Meredith M. 分享 收藏
Efficacy and immunological outcomes of non-fucosylated anti-CTLA-4 (BMS-986218) + degarelix acetate vs. degarelix acetate alone in men with high-risk localized prostate cancer (Neo-Red-P) McCann, Patrick J.; Ager, Casey R.; Obradovic, Aleksandar Z.; Chaimowitz, Matthew G.; Pan, Samuel; Laplaca, Caroline J.; Shah, Parin; Virk, Renu K.; Anderson, Christopher B.; Spina, Catherine S.; Runcie, Karie D.; Stein, Mark N.; Drake, Charles G.; Dallos, Matthew C. 分享 收藏
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes Zorko, Nicholas A.; Makovec, Allison; Elliott, Andrew; Kellen, Samuel; Lozada, John R.; Arafa, Ali T.; Felices, Martin; Shackelford, Madison; Barata, Pedro; Zakharia, Yousef; Narayan, Vivek; Stein, Mark N.; Zarrabi, Kevin K.; Patniak, Akash; Bilen, Mehmet A.; Radovich, Milan; Sledge, George; El-Deiry, Wafik S.; Heath, Elisabeth I.; Hoon, Dave S. B.; Nabhan, Chadi; Miller, Jeffrey S.; Hwang, Justin H.; Antonarakis, Emmanuel S. 分享 收藏
Adjuvant everolimus (EVE) in patients (pts) with completely resected very high-risk renal cell cancer (RCC) and clear cell histology: Results from the phase III SWOG S0931 (EVEREST) trial Lara, P. N.; Tangen, C.; Heath, E.; Stein, M.; Meng, M.; Alva, A.; Pal, S. K.; Puzanov, I.; Clark, J.; Choueiri, T. K.; Agarwal, N.; Uzzo, R.; Haas, N. B.; Plets, M.; Vaishampayan, U. N.; Shuch, B.; Thompson, I. M.; Ryan, C. W. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
.png){kind=icon}
分享.png){kind=icon}
收藏